Publications by authors named "FuJu Chou"

Claim this Profile
C
Correction: Androgen receptor promotes renal cell carcinoma (RCC) vasculogenic mimicry (VM) via altering TWIST1 nonsense-mediated decay through lncRNA-TANAR.
Bosen You, Yin Sun, Jie Luo, Keliang Wang, Qing Liu, Fuju Chou

Oncogene· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protein Kinase B (PKB/AKT) Protects IDH-Mutated Glioma from Ferroptosis via Nrf2.
Yang Liu, Fu-Ju Chou, Fengchao Lang, Meili Zhang, Hua Song

Clin Cancer Res· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the androgen receptor to enhance NK cell killing efficacy in bladder cancer by modulating ADAR2/circ_0001005/PD-L1 signaling.
Qing Liu, Bosen You, Jialin Meng, Chi-Ping Huang, Guanglu Dong, Fuju Chou

Cancer Gene Ther· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the radiation-induced ARv7-mediated circNHS/miR-512-5p/XRCC5 signaling with Quercetin increases prostate cancer radiosensitivity.
Dong Chen, Fu-Ju Chou, Yuhchyau Chen, Chi-Ping Huang, Hao Tian

J Exp Clin Cancer Res· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genotoxic therapy and resistance mechanism in gliomas.
Fengchao Lang, Yang Liu, Fu-Ju Chou, Chunzhang Yang

Pharmacol Ther· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
D-2-Hydroxyglutarate in Glioma Biology.
Fu-Ju Chou, Yang Liu, Fengchao Lang, Chunzhang Yang

Cells· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Androgen receptor promotes renal cell carcinoma (RCC) vasculogenic mimicry (VM) via altering TWIST1 nonsense-mediated decay through lncRNA-TANAR.
Bosen You, Yin Sun, Jie Luo, Keliang Wang, Qing Liu, Fuju Chou

Oncogene· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ASC-J9® suppresses prostate cancer cell proliferation and invasion via altering the ATF3-PTK2 signaling.
Hao Tian, Fu-Ju Chou, Jing Tian, Yong Zhang, Bosen You

J Exp Clin Cancer Res· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the radiation-induced TR4 nuclear receptor-mediated QKI/circZEB1/miR-141-3p/ZEB1 signaling increases prostate cancer radiosensitivity.
Dong Chen, Fu-Ju Chou, Yuhchyau Chen, Hao Tian, Yaqin Wang

Cancer Lett· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical studies using cisplatin/carboplatin to restore the Enzalutamide sensitivity via degrading the androgen receptor splicing variant 7 (ARv7) to further suppress Enzalutamide resistant prostate cancer.
Fu-Ju Chou, ChangYi Lin, Hao Tian, WanYing Lin, Bosen You

Cell Death Dis· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical studies show using enzalutamide is less effective in docetaxel-pretreated than in docetaxel-naïve prostate cancer cells.
Changyi Lin, Fu-Ju Chou, Jieyang Lu, Wanying Lin, Matthew Truong

Aging (Albany NY)· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isocitrate Dehydrogenase Mutations in Glioma: Genetics, Biochemistry, and Clinical Indications.
Yang Liu, Fengchao Lang, Fu-Ju Chou, Kareem A Zaghloul, Chunzhang Yang

Biomedicines· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Olaparib and enzalutamide synergistically suppress HCC progression via the AR-mediated miR-146a-5p/BRCA1 signaling.
Jie Zhao, Yin Sun, Hui Lin, Fuju Chou, Yao Xiao

FASEB J· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Protective Roles of Estrogen Receptor in Renal Calcium Oxalate Crystal Formation Reducing the Liver Oxalate Biosynthesis and Renal Oxidative Stress-Mediated Cell Injury.
Wei Zhu, Zhijian Zhao, Fu-Ju Chou, Li Zuo, Tongzu Liu

Oxid Med Cell Longev· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Androgen dihydrotestosterone (DHT) promotes the bladder cancer nuclear AR-negative cell invasion via a newly identified membrane androgen receptor (mAR-SLC39A9)-mediated Gαi protein/MAPK/MMP9 intracellular signaling.
Jinbo Chen, Fuju Chou, Shuyuan Yeh, Zhenyu Ou, Chihrong Shyr

Oncogene· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the androgen receptor (AR) with AR degradation enhancer ASC-J9® led to increase docetaxel sensitivity via suppressing the p21 expression.
Jie Luo, Jing Tian, FuJu Chou, Changyi Lin, Emily Zixin Xing

Cancer Lett· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss of the androgen receptor suppresses intrarenal calcium oxalate crystals deposition via altering macrophage recruitment/M2 polarization with change of the miR-185-5p/CSF-1 signals.
Wei Zhu, Zhijian Zhao, Fuju Chou, Li Zuo, Tongzu Liu

Cell Death Dis· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical study using androgen receptor (AR) degradation enhancer to increase radiotherapy efficacy via targeting radiation-increased AR to better suppress prostate cancer progression.
Fu-Ju Chou, Yuhchyau Chen, Dong Chen, Yuanjie Niu, Gonghui Li

EBioMedicine· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Androgen receptor (AR) degradation enhancer ASC-J9 in an FDA-approved formulated solution suppresses castration resistant prostate cancer cell growth.
Max A Cheng, Fu-Ju Chou, Keliang Wang, Rachel Yang, Jie Ding

Cancer Lett· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natural killer cells suppress enzalutamide resistance and cell invasion in the castration resistant prostate cancer via targeting the androgen receptor splicing variant 7 (ARv7).
Shin-Jen Lin, Fu-Ju Chou, Lei Li, Chang-Yi Lin, Shuyuan Yeh

Cancer Lett· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting fatty acid synthase with ASC-J9 suppresses proliferation and invasion of prostate cancer cells.
Simeng Wen, Yuanjie Niu, Soo Ok Lee, Shuyuan Yeh, Zhiqun Shang, Fuju Chou

Mol Carcinog· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New therapy with ASC-J9® to suppress the prostatitis via altering the cytokine CCL2 signals.
Shin-Jen Lin, Fu-Ju Chou, Chang-Yi Lin, Hong-Chiang Chang, Shuyuan Yeh

Oncotarget· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estrogen receptor α in cancer associated fibroblasts suppresses prostate cancer invasion via reducing CCL5, IL6 and macrophage infiltration in the tumor microenvironment.
Chiuan-Ren Yeh, Spencer Slavin, Jun Da, Iawen Hsu, Jie Luo, Fu-Ju Chou

Mol Cancer· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A nucleolus-predominant piggyBac transposase, NP-mPB, mediates elevated transposition efficiency in mammalian cells.
Jin-Bon Hong, Fu-Ju Chou, Amy T Ku, Hsiang-Hsuan Fan, Tung-Lung Lee

PLoS One· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
R26R-GR: a Cre-activable dual fluorescent protein reporter mouse.
You-Tzung Chen, Ming-Shian Tsai, Tsung-Lin Yang, Amy Tsu Ku, Ke-Han Huang, Fu-Ju Chou

PLoS One· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis